Real Endpoints
Pharmaceuticals, 25a Hanover Rd, Florham Park, New Jersey, 07932, United States, 11-50 Employees
Phone Number: +17*********
Who is REAL ENDPOINTS
Real Endpoints believes that the single biggest challenge to the long-term health of medical innovation is getting it paid for. In a world where healthcare decision-making is increasingly...
Read More
-
Headquarters: 25a Hanover Rd, Florham Park, New Jersey, 07932, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 6411
|
NAICS Code: 531210 |
Show More
Does something look wrong? Fix it. | View contact records from REAL ENDPOINTS
Real Endpoints Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Real Endpoints
Answer: Real Endpoints's headquarters are located at 25a Hanover Rd, Florham Park, New Jersey, 07932, United States
Answer: Real Endpoints's phone number is +17*********
Answer: Real Endpoints's official website is https://realendpoints.com
Answer: Real Endpoints's revenue is $5 Million to $10 Million
Answer: Real Endpoints's SIC: 6411
Answer: Real Endpoints's NAICS: 531210
Answer: Real Endpoints has 11-50 employees
Answer: Real Endpoints is in Pharmaceuticals
Answer: Real Endpoints contact info: Phone number: +17********* Website: https://realendpoints.com
Answer: Real Endpoints believes that the single biggest challenge to the long-term health of medical innovation is getting it paid for. In a world where healthcare decision-making is increasingly concentrated in a consolidating set of ever-more powerful industrial customers, RE focuses entirely on delivering solutions that enhance appropriate access to innovation. To do this, we leverage insights from our close working relationships with payers and biopharma; objective, data-driven proprietary tools; and above all the creativity and deep experience of our people. In particular, RE focuses on three main activities: Helping to define, through objective clinical and economic assessment and practical evidence strategies, a products value for patients and payers; Translating that value into coverage with effective pricing strategies and innovative, contracting approaches, including risk sharing and outcomes-focused arrangements; And finally, strategies for supporting patients and providers in order to go beyond mere coverage and win actual access to new diagnostics and medicines. To date, RE has worked with dozens of biopharmas, diagnostics players, and payers to make it possible for patients to benefit, affordably, from the extraordinary innovations of life science companies...and simultaneously keep the ultimate fuel of this industry meaningful reimbursement flowing.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month